nitroject inj 1mg/ml solution
omega laboratories limited - nitroglycérine - solution - 10mg - nitroglycérine 10mg - nitrates and nitrites
nitroject solution
omega laboratories limited - nitroglycérine - solution - 50mg - nitroglycérine 50mg - nitrates and nitrites
ropivacaine hydrochloride injection solution
teva canada limited - chlorhydrate de ropivacaïne - solution - 2mg - chlorhydrate de ropivacaïne 2mg - local anesthetics
nitroglycerin in 5% dextrose inj.-400mcg/ml solution
baxter corporation - nitroglycérine; dextrose - solution - 40mg; 5g - nitroglycérine 40mg; dextrose 5g - nitrates and nitrites
nitroglycerin in 5% dextrose inj.-200mcg/ml solution
baxter corporation - nitroglycérine; dextrose - solution - 20mg; 5g - nitroglycérine 20mg; dextrose 5g - nitrates and nitrites
nitroglycerin in 5% dextrose inj.-100mcg/ml solution
baxter corporation - nitroglycérine; dextrose - solution - 10mg; 5g - nitroglycérine 10mg; dextrose 5g - nitrates and nitrites
nexviadyme 100 mg poudre pour solution à diluer pour perfusion
sanofi-aventis (suisse) sa - avalglucosidasum alfa - poudre pour solution à diluer pour perfusion - avalglucosidasum alfa 100 mg, histidinum, histidini hydrochloridum monohydricum, glycinum, mannitolum, polysorbatum 80, pro vitro. - traitement de la maladie de stockage du glycogen de type ii (maladie de pompe) - biotechnologika
nexviadyme
sanofi b.v. - avalglucosidase alfa - maladie de stockage de glycogène type ii - d'autres tractus digestif et le métabolisme des produits, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
pdp-amantadine hydrochloride capsules
pendopharm division of pharmascience inc - chlorhydrate d'amantadine - capsule - 100mg - chlorhydrate d'amantadine 100mg - adamantanes
pdp-amantadine hydrochloride syrup sirop
pendopharm division of pharmascience inc - chlorhydrate d'amantadine - sirop - 50mg - chlorhydrate d'amantadine 50mg - adamantanes